WallStreetZenWallStreetZen

NASDAQ: ALT
Altimmune Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for ALT

Based on 7 analysts offering 12 month price targets for Altimmune Inc.
Min Forecast
$20.00+77.3%
Avg Forecast
$29.71+163.42%
Max Forecast
$50.00+343.26%

Should I buy or sell ALT stock?

Based on 7 analysts offering ratings for Altimmune Inc.
Strong Buy
Strong Buy
5 analysts 71.43%
Buy
2 analysts 28.57%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALT stock forecasts and price targets.

ALT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Goldman Sachs
Top 24%
77
Strong BuyInitiates Coverage On$20.00+77.30%2022-12-01
JMP Securities
Bottom 8%
8
BuyMaintains$26.00+130.50%2022-11-11
Guggenheim
Bottom 12%
12
Strong BuyMaintains$26.00+130.50%2022-09-16
Jefferies
Bottom 6%
6
Strong BuyMaintains$35.00+210.28%2022-08-31
HC Wainwright & Co.
Bottom 2%
2
BuyMaintains$50.00+343.26%2022-08-17
B. Riley Securities
Top 1%
100
Strong BuyMaintains$26.00+130.50%2022-08-12Find out why
Piper Sandler
Top 10%
91
Strong BuyMaintains$25.00+121.63%2022-05-18

1 of 1

Forecast return on equity

Is ALT forecast to generate an efficient return?
Company
-58.02%
Industry
13.87%
Market
62.54%
ALT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALT forecast to generate an efficient return on assets?
Company
-52.81%
Industry
13.22%
ALT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALT earnings per share forecast

What is ALT's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.86
Avg 2 year Forecast
-$2.10
Avg 3 year Forecast
-$2.36

ALT revenue forecast

What is ALT's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$3.6M+9.83%
Avg 2 year Forecast
$20.0M+502.47%
Avg 3 year Forecast
$30.0M+803.71%
ALT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALT revenue growth forecast

How is ALT forecast to perform vs Biotechnology companies and vs the US market?
Company
111.02%
Industry
25.22%
Market
6.8%
ALT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALT$11.28$29.71+163.42%Strong Buy
CGEM$12.11$32.67+169.75%Strong Buy
EWTX$8.86$24.00+170.88%Buy
ESPR$7.39$12.25+65.76%Hold
JANX$13.63N/AN/ABuy

Altimmune Stock Forecast FAQ

Is Altimmune Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: ALT) stock is to Strong Buy ALT stock.

Out of 7 analysts, 5 (71.43%) are recommending ALT as a Strong Buy, 2 (28.57%) are recommending ALT as a Buy, 0 (0%) are recommending ALT as a Hold, 0 (0%) are recommending ALT as a Sell, and 0 (0%) are recommending ALT as a Strong Sell.

If you're new to stock investing, here's how to buy Altimmune stock.

What is ALT's earnings growth forecast for 2022-2024?

(NASDAQ: ALT) Altimmune's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17%.

Altimmune's earnings in 2022 is -$86,942,321.On average, 3 Wall Street analysts forecast ALT's earnings for 2022 to be -$91,435,844, with the lowest ALT earnings forecast at -$94,385,388, and the highest ALT earnings forecast at -$85,536,757. On average, 4 Wall Street analysts forecast ALT's earnings for 2023 to be -$103,234,018, with the lowest ALT earnings forecast at -$116,506,963, and the highest ALT earnings forecast at -$81,112,442.

In 2024, ALT is forecast to generate -$116,015,372 in earnings, with the lowest earnings forecast at -$128,796,727 and the highest earnings forecast at -$94,876,978.

What is ALT's revenue growth forecast for 2022-2024?

(NASDAQ: ALT) Altimmune's forecast annual revenue growth rate of 111.02% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 25.22%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.8%.

Altimmune's revenue in 2022 is $3,319,658.On average, 3 Wall Street analysts forecast ALT's revenue for 2022 to be $179,233,918, with the lowest ALT revenue forecast at $19,663,622, and the highest ALT revenue forecast at $491,590,560. On average, 1 Wall Street analysts forecast ALT's revenue for 2023 to be $983,181,120, with the lowest ALT revenue forecast at $983,181,120, and the highest ALT revenue forecast at $983,181,120.

In 2024, ALT is forecast to generate $1,474,771,680 in revenue, with the lowest revenue forecast at $1,474,771,680 and the highest revenue forecast at $1,474,771,680.

What is ALT's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: ALT) forecast ROA is -52.81%, which is lower than the forecast US Biotechnology industry average of 13.22%.

What is ALT's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ALT price target, the average ALT price target is $29.71, with the highest ALT stock price forecast at $50.00 and the lowest ALT stock price forecast at $20.00.

On average, Wall Street analysts predict that Altimmune's share price could reach $29.71 by Dec 1, 2023. The average Altimmune stock price prediction forecasts a potential upside of 163.42% from the current ALT share price of $11.28.

What is ALT's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: ALT) Altimmune's current Earnings Per Share (EPS) is -$1.90. On average, analysts forecast that ALT's EPS will be -$1.86 for 2022, with the lowest EPS forecast at -$1.92, and the highest EPS forecast at -$1.74. On average, analysts forecast that ALT's EPS will be -$2.10 for 2023, with the lowest EPS forecast at -$2.37, and the highest EPS forecast at -$1.65. In 2024, ALT's EPS is forecast to hit -$2.36 (min: -$2.62, max: -$1.93).

What is ALT's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: ALT) forecast ROE is -58.02%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.